PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Polyherbal compositions containing E. intermedia (Gangjihwan) inhibited fat accumulation in high-fat diet-induced obese mice and 3T3-L1 adipocytes [PMID:28842339, 28602867].
Specific isolated compounds from E. intermedia (compound 6) exhibited a significant protective effect against LPS-induced injury in human pulmonary epithelial cells (BEAS-2B) in vitro [PMID:38257345].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 28822149 (2017) — [Ecology suitability study of Ephedra intermedia]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
- 2.PMID: 36641108 (2023) — Ephedrae herba: A comprehensive review of its traditional uses, phytochemistry, pharmacology, and toxicology. · Journal of ethnopharmacology
- 3.PMID: 36840134 (2023) — Modeling for Predicting the Potential Geographical Distribution of Three Ephedra Herbs in China. · Plants (Basel, Switzerland)
- 4.PMID: 15684485 (2005) — Survey on resources of Ephedra plants in Xinjiang. · Biological & pharmaceutical bulletin
- 5.PMID: 40092909 (2025) — From Ecological Niche to Conservation Planning; Climate-Driven Range Dynamics of Ephedra intermedia in Central Asia.